Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion type Assertion NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_head.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion wasGeneratedBy ECO_0000203 NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_provenance.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion wasDerivedFrom befree-2016 NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_provenance.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion SIO_000772 17699277 NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_provenance.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion evidence source_evidence_literature NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_provenance.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_provenance.